HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening of potentially toxic chalcogens in erythrocytes.

Abstract
Previous literature reports have demonstrated that a number of human diseases, including inflammation and cancer, can be caused by environmental and occupational exposure to toxic compounds, via DNA damage, protein modifications, or lipid peroxidation. The present study was undertaken to screen the toxicity of a variety of chalcogens using erythrocytes as a model of cell injury. The toxicity of these compounds was evaluated via quantification of hemolysis and lipid peroxidation. The present investigation shows that diphenyl ditelluride and phenyl tellurides are toxic to erythrocytes. The organoselenium compounds were not toxic to erythrocytes even when tested at high concentrations and with a hematocrit of 45%. The hemolytic effect of tellurides was not positively correlated with thiobarbituric acid-reactive substance (TBARS) production suggesting that lipid peroxidation is not involved in the hemolysis provoked by organotellurium compounds. The results suggest that chalcogen compounds may be toxic to human erythrocytes, depending on their structure.
AuthorsViviane Patrícia P Schiar, Danúbia B Dos Santos, Diogo S Lüdtke, Fabrício Vargas, Márcio W Paixão, Cristina W Nogueira, Gilson Zeni, João Batista T Rocha
JournalToxicology in vitro : an international journal published in association with BIBRA (Toxicol In Vitro) Vol. 21 Issue 1 Pg. 139-45 (Feb 2007) ISSN: 0887-2333 [Print] England
PMID17084588 (Publication Type: Journal Article)
Chemical References
  • Chalcogens
  • Indicators and Reagents
  • Organic Chemicals
  • Oxidants
  • Thiobarbituric Acid Reactive Substances
Topics
  • Chalcogens (toxicity)
  • Erythrocytes (drug effects)
  • Hemolysis (drug effects)
  • Humans
  • In Vitro Techniques
  • Indicators and Reagents
  • Lipid Peroxidation (drug effects)
  • Organic Chemicals (toxicity)
  • Oxidants (toxicity)
  • Thiobarbituric Acid Reactive Substances

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: